Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Receivables (2016 - 2025)

Historic Receivables for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to $1.5 million.

  • Jaguar Health's Receivables rose 1516.08% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 1516.08%. This contributed to the annual value of $1.6 million for FY2024, which is 2458.79% down from last year.
  • Latest data reveals that Jaguar Health reported Receivables of $1.5 million as of Q3 2025, which was up 1516.08% from $1.3 million recorded in Q2 2025.
  • Over the past 5 years, Jaguar Health's Receivables peaked at $5.9 million during Q1 2021, and registered a low of $1.3 million during Q3 2024.
  • For the 5-year period, Jaguar Health's Receivables averaged around $2.2 million, with its median value being $1.8 million (2023).
  • As far as peak fluctuations go, Jaguar Health's Receivables soared by 44526.22% in 2021, and later plummeted by 6195.38% in 2022.
  • Over the past 5 years, Jaguar Health's Receivables (Quarter) stood at $2.1 million in 2021, then grew by 15.07% to $2.5 million in 2022, then dropped by 11.47% to $2.2 million in 2023, then decreased by 24.59% to $1.6 million in 2024, then decreased by 8.68% to $1.5 million in 2025.
  • Its Receivables was $1.5 million in Q3 2025, compared to $1.3 million in Q2 2025 and $1.4 million in Q1 2025.